BRCA2 and cancer: Together, these results provide further evidence that cancer-causing BRCA2 missense mutations disrupt a DSS1-mediated intracellular protein assembly mechanism essential for its function in DNA repair by HDR, and suggest an approach for therapeutic correction via drugs that mimic the effects of DSS1 binding.